Skip to main content

Roche's Half-Year Results 2024 Presentation

Roche has published its Half-Year Results for 2024 prior to the opening of the Swiss Stock Exchange on Thursday, 25 July 2024.

Agenda
OverviewThomas Schinecker, CEO Roche Group
Financial ResultsAlan Hippe, Chief Financial and IT Officer
Pharmaceuticals DivisionTeresa Graham, CEO Roche Pharmaceuticals
Diagnostics DivisionMatt Sause, CEO Roche Diagnostics
Questions and answersBruno Eschli, Head of Investor Relations

Webinar Replay

InvestorsPast IR Events
View more Events

Downloads

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.